vs

Side-by-side financial comparison of NATIONAL RESEARCH CORP (NRC) and OneMedNet Corp (ONMD). Click either name above to swap in a different company.

NATIONAL RESEARCH CORP is the larger business by last-quarter revenue ($35.2M vs $890.0K, roughly 39.5× OneMedNet Corp). NATIONAL RESEARCH CORP runs the higher net margin — 5.1% vs -352.8%, a 357.9% gap on every dollar of revenue. On growth, OneMedNet Corp posted the faster year-over-year revenue change (3323.1% vs -4.6%). NATIONAL RESEARCH CORP produced more free cash flow last quarter ($6.1M vs $-1.7M). Over the past eight quarters, OneMedNet Corp's revenue compounded faster (89.4% CAGR vs -0.2%).

National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.

OneMedNet Corp is a U.S.-headquartered healthcare tech firm offering secure cloud-based data sharing and workflow solutions for medical imaging and patient health information. It serves healthcare providers, insurance payers, and life sciences groups, with its core operating market centered in North America.

NRC vs ONMD — Head-to-Head

Bigger by revenue
NRC
NRC
39.5× larger
NRC
$35.2M
$890.0K
ONMD
Growing faster (revenue YoY)
ONMD
ONMD
+3327.7% gap
ONMD
3323.1%
-4.6%
NRC
Higher net margin
NRC
NRC
357.9% more per $
NRC
5.1%
-352.8%
ONMD
More free cash flow
NRC
NRC
$7.8M more FCF
NRC
$6.1M
$-1.7M
ONMD
Faster 2-yr revenue CAGR
ONMD
ONMD
Annualised
ONMD
89.4%
-0.2%
NRC

Income Statement — Q4 2025 vs Q4 2025

Metric
NRC
NRC
ONMD
ONMD
Revenue
$35.2M
$890.0K
Net Profit
$1.8M
$-3.1M
Gross Margin
20.7%
Operating Margin
13.3%
-353.4%
Net Margin
5.1%
-352.8%
Revenue YoY
-4.6%
3323.1%
Net Profit YoY
-72.6%
-32.3%
EPS (diluted)
$49.58
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NRC
NRC
ONMD
ONMD
Q4 25
$35.2M
$890.0K
Q3 25
$34.6M
$177.0K
Q2 25
$34.0M
$155.0K
Q1 25
$33.6M
$137.0K
Q4 24
$36.9M
$26.0K
Q3 24
$35.8M
$142.0K
Q2 24
$35.0M
$227.0K
Q1 24
$35.3M
$248.0K
Net Profit
NRC
NRC
ONMD
ONMD
Q4 25
$1.8M
$-3.1M
Q3 25
$4.1M
$-741.0K
Q2 25
$-106.0K
$3.0M
Q1 25
$5.8M
$-1.9M
Q4 24
$6.6M
$-2.4M
Q3 24
$5.7M
$-2.1M
Q2 24
$6.2M
$-3.6M
Q1 24
$6.4M
$-2.1M
Gross Margin
NRC
NRC
ONMD
ONMD
Q4 25
20.7%
Q3 25
-125.4%
Q2 25
-155.5%
Q1 25
-163.5%
Q4 24
-100.0%
Q3 24
-59.2%
Q2 24
-44.9%
Q1 24
-27.8%
Operating Margin
NRC
NRC
ONMD
ONMD
Q4 25
13.3%
-353.4%
Q3 25
22.4%
-1262.7%
Q2 25
4.7%
-1331.0%
Q1 25
25.6%
-1623.4%
Q4 24
26.0%
-10438.5%
Q3 24
22.3%
-1645.1%
Q2 24
25.3%
-1081.1%
Q1 24
24.8%
-847.2%
Net Margin
NRC
NRC
ONMD
ONMD
Q4 25
5.1%
-352.8%
Q3 25
11.9%
-418.6%
Q2 25
-0.3%
1923.9%
Q1 25
17.2%
-1388.3%
Q4 24
17.8%
-9126.9%
Q3 24
15.9%
-1449.3%
Q2 24
17.6%
-1581.1%
Q1 24
18.0%
-850.4%
EPS (diluted)
NRC
NRC
ONMD
ONMD
Q4 25
$49.58
$-0.06
Q3 25
$0.18
$-0.01
Q2 25
$-0.01
$0.07
Q1 25
$0.25
$-0.06
Q4 24
$0.27
$-0.07
Q3 24
$0.24
$-0.07
Q2 24
$0.26
$-0.14
Q1 24
$0.27
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NRC
NRC
ONMD
ONMD
Cash + ST InvestmentsLiquidity on hand
$4.1M
$585.0K
Total DebtLower is stronger
$220.0K
Stockholders' EquityBook value
$14.0M
$-3.0M
Total Assets
$134.9M
$2.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NRC
NRC
ONMD
ONMD
Q4 25
$4.1M
$585.0K
Q3 25
$2.2M
$149.0K
Q2 25
$5.3M
$122.0K
Q1 25
$2.5M
$144.0K
Q4 24
$4.2M
$172.0K
Q3 24
$3.5M
$1.9M
Q2 24
$485.0K
$407.0K
Q1 24
$1.7M
$174.0K
Total Debt
NRC
NRC
ONMD
ONMD
Q4 25
$220.0K
Q3 25
Q2 25
Q1 25
$2.3M
Q4 24
$2.3M
Q3 24
$48.7M
$2.3M
Q2 24
$33.3M
$2.4M
Q1 24
$35.2M
Stockholders' Equity
NRC
NRC
ONMD
ONMD
Q4 25
$14.0M
$-3.0M
Q3 25
$14.3M
$-3.9M
Q2 25
$21.3M
$-3.8M
Q1 25
$29.7M
$-16.6M
Q4 24
$31.3M
$-15.9M
Q3 24
$34.6M
$-14.3M
Q2 24
$40.2M
$-19.2M
Q1 24
$36.9M
$-15.7M
Total Assets
NRC
NRC
ONMD
ONMD
Q4 25
$134.9M
$2.2M
Q3 25
$135.7M
$1.5M
Q2 25
$141.4M
$2.3M
Q1 25
$135.2M
$1.7M
Q4 24
$132.5M
$3.7M
Q3 24
$131.8M
$4.4M
Q2 24
$119.1M
$1.0M
Q1 24
$120.9M
$750.0K
Debt / Equity
NRC
NRC
ONMD
ONMD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.41×
Q2 24
0.83×
Q1 24
0.95×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NRC
NRC
ONMD
ONMD
Operating Cash FlowLast quarter
$7.2M
$-1.7M
Free Cash FlowOCF − Capex
$6.1M
$-1.7M
FCF MarginFCF / Revenue
17.2%
-193.0%
Capex IntensityCapex / Revenue
3.2%
0.6%
Cash ConversionOCF / Net Profit
3.99×
TTM Free Cash FlowTrailing 4 quarters
$15.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NRC
NRC
ONMD
ONMD
Q4 25
$7.2M
$-1.7M
Q3 25
$13.8M
$-1.6M
Q2 25
$-1.1M
$-2.3M
Q1 25
$6.6M
$-1.9M
Q4 24
$6.4M
$-2.0M
Q3 24
$9.4M
$-1.9M
Q2 24
$6.8M
$-1.5M
Q1 24
$12.0M
$-1.5M
Free Cash Flow
NRC
NRC
ONMD
ONMD
Q4 25
$6.1M
$-1.7M
Q3 25
$10.2M
Q2 25
$-4.1M
$-2.3M
Q1 25
$3.7M
$-2.0M
Q4 24
$1.9M
$-2.0M
Q3 24
$7.8M
$-1.9M
Q2 24
$1.5M
$-1.5M
Q1 24
$7.9M
$-1.6M
FCF Margin
NRC
NRC
ONMD
ONMD
Q4 25
17.2%
-193.0%
Q3 25
29.4%
Q2 25
-12.2%
-1475.5%
Q1 25
10.9%
-1425.5%
Q4 24
5.2%
-7811.5%
Q3 24
21.8%
-1346.5%
Q2 24
4.3%
-663.9%
Q1 24
22.4%
-626.2%
Capex Intensity
NRC
NRC
ONMD
ONMD
Q4 25
3.2%
0.6%
Q3 25
10.4%
0.0%
Q2 25
8.8%
1.9%
Q1 25
8.9%
3.6%
Q4 24
12.0%
134.6%
Q3 24
4.5%
6.3%
Q2 24
15.0%
0.4%
Q1 24
11.7%
2.4%
Cash Conversion
NRC
NRC
ONMD
ONMD
Q4 25
3.99×
Q3 25
3.34×
Q2 25
-0.77×
Q1 25
1.15×
Q4 24
0.97×
Q3 24
1.66×
Q2 24
1.10×
Q1 24
1.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons